---
layout: post
title: 'Papers: Drug Target Central'
date: '2009-09-06T19:00:00.010+01:00'
author: John Overington
tags:
- Books and Papers
- DrugEBIlity
modified_time: '2009-09-06T19:22:29.382+01:00'
thumbnail: http://1.bp.blogspot.com/_SlPG9DIz_AA/SqP792bU_yI/AAAAAAAAAd8/RW8g3d0-M_A/s72-c/442033078_81e0f6baf8.jpg
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-3543609124350022816
blogger_orig_url: http://chembl.blogspot.com/2009/09/papers-drug-target-central.html
---

<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_SlPG9DIz_AA/SqP792bU_yI/AAAAAAAAAd8/RW8g3d0-M_A/s1600-h/442033078_81e0f6baf8.jpg"><img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 200px; height: 134px;" src="http://1.bp.blogspot.com/_SlPG9DIz_AA/SqP792bU_yI/AAAAAAAAAd8/RW8g3d0-M_A/s200/442033078_81e0f6baf8.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5378419420011233058" /></a>
<P>
<A HREF="http://www.informahealthcare.com/doi/pdf/10.1517/17460440903049290">Here</A> is a paper (subscription required). It is written by Lee Harland (Pfizer Regenerative Medicine) and Anna Gaulton (ex Pfizer, but now in the ChEMBL group at the EMBL-EBI). It is an overview of Drug Targets, and some of the general principles of 'druggability' and ways to assess target tractability for drug discovery. In particular, the challenges of data integration are discussed.
<P>
<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_SlPG9DIz_AA/SqP9FTl9R4I/AAAAAAAAAeE/0RrdhyLennE/s1600-h/paper.png"><img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 246px; height: 320px;" src="http://4.bp.blogspot.com/_SlPG9DIz_AA/SqP9FTl9R4I/AAAAAAAAAeE/0RrdhyLennE/s320/paper.png" border="0" alt=""id="BLOGGER_PHOTO_ID_5378420647611156354" /></a>
<PRE>
%A L. Harland 
%A A. Gaulton
%T Drug Target Central
%J Expert Opin. Drug. Disc.
%V 4
%P 857-872
%D 2009
</PRE>